Medication info

Toburex Injection (Dobutamine Hydrochloride)

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Dobutamine Hydrochloride›280.3mg / 1 ampoule
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
A transparent liquid that is colorless to light yellow contained in a colorless transparent ampoule injection.
Packaging
5mL/ampoule × 10
Approval status
Active

MFDS item code 199000148 · Notified 1990.09.18 · Insurance code 658601761

Summary

Main use
Short-term treatment of heart failure associated with heart disease or cardiac surgery
Who receives it
Adults
Adult administration
Adults: Administer dobutamine intravenously at 2.5-10㎍/min per kg of body weight. In rare cases, an infusion rate of 40㎍/min per kg of body weight may be required to achieve a satisfactory effect. In patients with atrial fibrillation and a rapid ventricular response, use a digitalis preparation before treatment with this drug. The administration rate and duration of treatment should be adjusted according to the patient's response, as determined by heart rate, the presence of ectopic activity, blood pressure, urine output, central venous pressure or pulmonary wedge pressure when available, and cardiac output. Diluent infusion rates by drug infusion rate (㎍/㎏/min): 2.5: 250㎍/ml 0.01(ml/㎏/min), 500㎍/ml 0.005(ml/㎏/min), 1000㎍/ml 0.0025(ml/㎏/min) 5: 250㎍/ml 0.02(ml/㎏/min), 500㎍/ml 0.01(ml/㎏/min), 1000㎍/ml 0.005(ml/㎏/min) 7.5: 250㎍/ml 0.03(ml/㎏/min), 500㎍/ml 0.015(ml/㎏/min), 1000㎍/ml 0.0075(ml/㎏/min) 10: 250㎍/ml 0.04(ml/㎏/min), 500㎍/ml 0.02(ml/㎏/min), 1000㎍/ml 0.01(ml/㎏/min) 12.5: 250㎍/ml 0.05(ml/㎏/min), 500㎍/ml 0.025(ml/㎏/min), 1000㎍/ml 0.0125(ml/㎏/min) 15: 250㎍/ml 0.06(ml/㎏/min), 500㎍/ml 0.03(ml/㎏/min), 1000㎍/ml 0.015(ml/㎏/min) There is experience administering concentrations of up to 5,000㎍/㎖(250㎎/50㎖) to humans. The final administered dose is determined by the patient's fluid requirements. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Short-term treatment of heart failure associated with heart disease or cardiac surgery

View approved original text

This medication is used to temporarily increase cardiac output in patients with heart failure who have weakened cardiac contractility due to heart disease or post-heart surgery. It helps the heart pump blood more efficiently, ensuring sufficient blood supply to the entire body. This helps alleviate symptoms of heart failure and contributes to the improvement of cardiac function.

How it is given

Adult administration

Adults: Administer dobutamine intravenously at 2.5-10㎍/min per kg of body weight. In rare cases, an infusion rate of 40㎍/min per kg of body weight may be required to achieve a satisfactory effect. In patients with atrial fibrillation and a rapid ventricular response, use a digitalis preparation before treatment with this drug. The administration rate and duration of treatment should be adjusted according to the patient's response, as determined by heart rate, the presence of ectopic activity, blood pressure, urine output, central venous pressure or pulmonary wedge pressure when available, and cardiac output. Diluent infusion rates by drug infusion rate (㎍/㎏/min): 2.5: 250㎍/ml 0.01(ml/㎏/min), 500㎍/ml 0.005(ml/㎏/min), 1000㎍/ml 0.0025(ml/㎏/min) 5: 250㎍/ml 0.02(ml/㎏/min), 500㎍/ml 0.01(ml/㎏/min), 1000㎍/ml 0.005(ml/㎏/min) 7.5: 250㎍/ml 0.03(ml/㎏/min), 500㎍/ml 0.015(ml/㎏/min), 1000㎍/ml 0.0075(ml/㎏/min) 10: 250㎍/ml 0.04(ml/㎏/min), 500㎍/ml 0.02(ml/㎏/min), 1000㎍/ml 0.01(ml/㎏/min) 12.5: 250㎍/ml 0.05(ml/㎏/min), 500㎍/ml 0.025(ml/㎏/min), 1000㎍/ml 0.0125(ml/㎏/min) 15: 250㎍/ml 0.06(ml/㎏/min), 500㎍/ml 0.03(ml/㎏/min), 1000㎍/ml 0.015(ml/㎏/min) There is experience administering concentrations of up to 5,000㎍/㎖(250㎎/50㎖) to humans. The final administered dose is determined by the patient's fluid requirements. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should be used with extreme caution as glass fragments may mix when cutting the injection container, especially in children and the elderly. It should not be administered to patients with specific heart diseases or allergies to this medication. Use with caution in patients with hypertension or severe heart disease, as heart rate or blood pressure may increase. This medication can cause allergic reactions, and patients with asthma should be particularly cautious. During administration, continuous monitoring of blood pressure, heart rate, electrocardiogram, etc., is necessary to closely observe the patient's condition. Patients with insufficient blood volume should have their volume restored before administration of this medication. There may be interactions when used with other medications, so it is essential to consult medical professionals. Women who are pregnant or breastfeeding should carefully weigh benefits and risks before using this medication and should ideally discontinue breastfeeding if possible. Safety in children has not been established, and use is not recommended. In the elderly, bodily functions may be diminished, so start with a low dose and administer while closely monitoring their condition. This medication should only be administered as an intravenous drip, and care must be taken to avoid extravasation as it may cause damage to the injection site. Do not mix with specific solutions during dilution, and use within 24 hours after preparation. Overdosage may cause abnormalities in blood pressure or heart rate; thus, if symptoms arise, administration should be stopped or reduced to stabilize the patient.

Side effects

  • Rash
  • fever
  • eosinophilia
  • bronchospasm
  • tachycardia
  • extrasystole
  • excessive blood pressure increase
  • angina
  • anterior chest heat sensation
  • chest discomfort
Show 9 more
  • palpitations
  • shortness of breath
  • hypotension
  • stress-induced cardiomyopathy
  • abdominal pain
  • nausea
  • injection site erythema
  • injection site swelling
  • headache

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air exposure, and it is advisable to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

A transparent liquid that is colorless to light yellow contained in a colorless transparent ampoule injection.

Package unit

5mL/ampoule × 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.